Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Zicam Pre-Cold Medicine Products
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Class-Action Tracker
Zicam Products
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Zicam Pre-Cold Remedies
The Latest
There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
TINA.org Action Sheds Light on SunPowerLED’s False Endorsement Claims
Letters alert agencies and organizations to company’s improper marketing.
VIN History USA’s ‘Free’ VIN Report
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
Will the MLM Industry Fix Its Earnings Claims Problem?
New research points to “no.”
TINA.org Supports Citizen Petition Calling for AI Pricing Transparency
Why disclosures are key to protecting informed consumer choice and competition.